Allan M. Fox - 31 May 2024 Form 4 Insider Report for REGENXBIO Inc. (RGNX)

Role
Director
Signature
/s/ Patrick J. Christmas as attorney-in-fact
Issuer symbol
RGNX
Transactions as of
31 May 2024
Net transactions value
$0
Form type
4
Filing time
04 Jun 2024, 16:41:04 UTC
Previous filing
06 Jun 2023
Next filing
03 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGNX Common Stock Award $0 +4,790 +74% $0.000000 11,286 31 May 2024 Direct F1
holding RGNX Common Stock 722,485 31 May 2024 By AMF Family Gift Trust LLC F2
holding RGNX Common Stock 315,000 31 May 2024 By AMF Gift Trust LLC F2
holding RGNX Common Stock 315,000 31 May 2024 By HBF Gift Trust LLC F2
holding RGNX Common Stock 1,529,981 31 May 2024 By Quaker Gray LLC F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGNX Stock Options (Right to Buy) Award $0 +24,454 $0.000000 24,454 31 May 2024 Common Stock 24,454 $14.35 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on May 1, 2025 subject to the continuous service of the recipient to the Issuer.
F2 The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 The option will vest in 12 equal monthly installments following May 31, 2024 subject to the continuous service of the optionee to the Issuer.